New Details on the Revision of USP Chapter 1
Recommendation
22/23 September 2026
Organisation of a GMP-compliant Site Change
On the Road to 30,000 Members
Let us become the World's Leading GMP/GDP Compliance Community in 2026
As already reported in the news "Second Revision of USP Chapter <1> Injections and Implanted Drug Products (Parenterals)-Product Quality Tests", USP's Chapter <1> "Injections and Implanted Drug Products (Parenterals)-Product Quality Tests' has been revised again. New information is now available.
The USP published these details on 25 March. The revised version now contains a table of contents for a better overview whereas the Product Performance Test at the end of the Chapter has been deleted. All details about the new version of USP's Chapter <1> can be found on the USP website.
The revised Chapter will become effective on May 1st, 2016.
Related GMP News
02.09.2026New Q&A Document on Visual Inspection of Parenterals
02.09.2026What are the Requirements for GMP-compliant Water Systems?
26.08.2026Who has to sign a URS?
19.08.2026Poor Airflow Visualisation at European Manufacturer of Sterile Veterinary Medicinal Products
12.08.2026European Inspection uncovers serious Deficiencies at Indian Sterile Manufacturer